Table 2.
Time point | Screening | Enrolment and fitting | Postallocation | Follow-up | Follow-up | Follow-up | |||
Screening | Enrolment | Telephone call | Interim visit | Telephone call | Endpoint visit | ||||
t - 10wks | t = 0 | t + 3wks | t + 6wks | t + 9wks | t + 12wks | t + 18wks | t + 38wks | t + 64wks | |
Enrolment | |||||||||
Eligibility screen | X | ||||||||
Informed consent | X | ||||||||
Allocation | X | ||||||||
Training on device usage. | X | ||||||||
Review of device usage data log with participant. | X | ||||||||
Encourage patient compliance. | X | X | X | X | |||||
Return device. | X | ||||||||
Interventions | |||||||||
Arm 1 | X | X | X | X | X | ||||
Arm 2 | X | X | X | X | X | ||||
Arm 3 | X | X | X | X | X | ||||
Assessments | |||||||||
Medical history | X | ||||||||
Previous or concomitant medications/illnesses | X | X | X | X | X | X | |||
Tinnitus location & tonality | X | X | X | X | X | X | X | ||
Audiometric tests of hearing | X | X | |||||||
Loudness Discomfort Level (LDL) | X | X | |||||||
Mini-Mental State Examination (MMSE) | X | ||||||||
Somatic assessment | X | ||||||||
Oral assessment | X | X | |||||||
Regensburg Insomnia Scale | X | X | |||||||
State-Trait Anxiety Inventory (STAI) | X | X | X | ||||||
Tinnitus Functional Index (TFI) | X | X | X | X | X | X | |||
Minimum Masking Level (MML) | X | X | X | X | X | X | X | ||
Tinnitus Loudness Matching (TLM) | X | X | X | X | X | X | X | ||
Tinnitus Handicap Inventory (THI) | X | X | X | X | X | X | X | ||
Visual Analogue Scale (VAS) (loudness and intrusiveness) | X | X | X | X | X | ||||
Adverse events | X | X | X | X | X | X | |||
Clinical Global Impression (CGI) (loudness and intrusiveness) | X | X | X | X | X | ||||
Device usability questionnaire | X | ||||||||
Hyperacusis questionnaire | X1 | X2 |
wk, week.
Dublin, 2Germany.